KATY SHURILLA: Open Payments
NPI 1538304381 · CANFIELD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,840 in 100 payments from 23 companies in 2025. Trend: 2023 $1,140 · 2024 $1,618 · 2025 $1,840
Food & beverage: $1,840
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $242 |
| Bayer Healthcare Pharmaceuticals Inc. | 19 | $206 |
| ABBVIE INC. | 12 | $185 |
| Dexcom, Inc. | 5 | $168 |
| Abbott Laboratories | 9 | $163 |
| Ascendis Pharma Endocrinology Inc | 6 | $141 |
| Lilly USA, LLC | 6 | $114 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $97 |
| Xeris Pharmaceuticals, Inc. | 4 | $76 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $60 |
Products named: Ozempic, Kerendia, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, Yorvipath, JARDIANCE, MOUNJARO, ISTURISA.
Industry payments across OH — which companies pay providers there.
